The discovery could be a route to novel treatments for the autoimmune disease.
Fromson joined Michigan Medicine in March 2021. He covers the neurosciences and cardiovascular medicine. He spent three years as a television reporter in West Michigan and is passionate about multimedia storytelling. Twitter: @noahfromson
Pain scores were similar despite opioid consumption decreasing.
The technology developed at the University of Michigan continuously uses data from a single electrocardiogram lead.
Researchers say the findings suggest more clinicians are carefully considering the risks of prescribing opioids.
The fluorine-based agent replaces an iodine-based agent developed decades ago at the University of Michigan.
It's the largest study to examine opioid prescription patterns for adults living with cerebral palsy and spina bifida.